Ingmar Jungner

8.7k total citations · 1 hit paper
107 papers, 6.1k citations indexed

About

Ingmar Jungner is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Surgery. According to data from OpenAlex, Ingmar Jungner has authored 107 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Endocrinology, Diabetes and Metabolism, 32 papers in Cancer Research and 30 papers in Surgery. Recurrent topics in Ingmar Jungner's work include Diabetes, Cardiovascular Risks, and Lipoproteins (34 papers), Cancer, Lipids, and Metabolism (31 papers) and Lipoproteins and Cardiovascular Health (26 papers). Ingmar Jungner is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (34 papers), Cancer, Lipids, and Metabolism (31 papers) and Lipoproteins and Cardiovascular Health (26 papers). Ingmar Jungner collaborates with scholars based in Sweden, United Kingdom and Norway. Ingmar Jungner's co-authors include Göran Walldius, Ingar Holme, Are H. Aastveit, Niklas Hammar, Eugen Steiner, Hans Garmo, Mieke Van Hemelrijck, Lars Holmberg, Mats Lambe and Håkan Malmström and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ingmar Jungner

106 papers receiving 5.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study

2001 975 citations Göran Walldius, Ingmar Jungner et al. The Lancet profile →

Peers

Countries citing papers authored by Ingmar Jungner

Since Specialization

Citations

This map shows the geographic impact of Ingmar Jungner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingmar Jungner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingmar Jungner more than expected).

Fields of papers citing papers by Ingmar Jungner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingmar Jungner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingmar Jungner. The network helps show where Ingmar Jungner may publish in the future.

Co-authorship network of co-authors of Ingmar Jungner

This figure shows the co-authorship network connecting the top 25 collaborators of Ingmar Jungner. A scholar is included among the top collaborators of Ingmar Jungner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingmar Jungner. Ingmar Jungner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Chronic inflammation markers are associated with risk of pancreatic cancer in the Swedish AMORIS cohort study 2019 ·BMC Cancer ·Sam Sollie, Dominique S. Michaud, Debashis Sarker, Sophia N. Karagiannis, Debra H. Josephs, Niklas Hammar, Aida Santaolalla, Göran Walldius, Hans Garmo, Lars Holmberg, Ingmar Jungner, Mieke Van Hemelrijck	30
2	Serum inflammatory markers and colorectal cancer risk and survival 2017 ·British Journal of Cancer ·(unknown), Mieke Van Hemelrijck, Hans Garmo, Lars Holmberg, Håkan Malmström, Mats Lambe, Niklas Hammar, Göran Walldius, Ingmar Jungner, Wahyu Wulaningsih	62
3	Gunnar Jungner and the Principles and Practice of Screening for Disease 2017 ·International Journal of Neonatal Screening ·(unknown), Ingmar Jungner, Martin Engvall, Ulrika von Döbeln	9
4	Investigating the association between allergen-specific immunoglobulin E, cancer risk and survival 2016 ·OncoImmunology ·Wahyu Wulaningsih, Lars Holmberg, Hans Garmo, Sophia N. Karagiannis, S. Ahlstedt, Håkan Malmström, Mats Lambe, Niklas Hammar, Göran Walldius, Ingmar Jungner, Tony Ng, Mieke Van Hemelrijck	28
5	Low fructosamine and mortality – A long term follow-up of 215,011 non-diabetic subjects in the Swedish AMORIS study 2016 ·Nutrition Metabolism and Cardiovascular Diseases ·Håkan Malmström, Per Wändell, Martin J. Holzmann, Johan Ärnlöv, Ingmar Jungner, Niklas Hammar, Göran Walldius, Axel C. Carlsson	7
6	Prediagnostic serum inflammatory markers in relation to breast cancer risk, severity at diagnosis and survival in breast cancer patients 2015 ·Carcinogenesis ·Wahyu Wulaningsih, Lars Holmberg, Hans Garmo, Håkan Malmström, Mats Lambe, Niklas Hammar, Göran Walldius, Ingmar Jungner, Mieke Van Hemelrijck	39
7	The History of the AutoChemist®: From Vision to Reality 2014 ·Yearbook of Medical Informatics ·(unknown), Ingmar Jungner	3
8	Biomarker-based score to predict mortality in persons aged 50 years and older: a new approach in the Swedish AMORIS study. 2012 ·Research Portal (King's College London) ·Mieke Van Hemelrijck, Danielle Harari, Hans Garmo, Niklas Hammar, Göran Walldius, Mats Lambe, Ingmar Jungner, Lars Holmberg	29
9	Serum calcium and incident and fatal prostate cancer in the Swedish AMORIS study 2012 ·Cancer Causes & Control ·Mieke Van Hemelrijck, (unknown), Karl Michaëlsson, Jennifer Melvin, Hans Garmo, Niklas Hammar, Ingmar Jungner, Göran Walldius, Lars Holmberg	16
10	Low levels of apolipoprotein A-I and HDL are associated with risk of prostate cancer in the Swedish AMORIS study 2011 ·Cancer Causes & Control ·Mieke Van Hemelrijck, Göran Walldius, Ingmar Jungner, Niklas Hammar, Hans Garmo, Elisa Binda, Adrian Hayday, Mats Lambe, Lars Holmberg	55
11	Gamma-glutamyltransferase and risk of cancer in a cohort of 545,460 persons – the Swedish AMORIS study 2011 ·European Journal of Cancer ·Mieke Van Hemelrijck, Wayel Jassem, Göran Walldius, Ian S. Fentiman, Niklas Hammar, Mats Lambe, Hans Garmo, Ingmar Jungner, Lars Holmberg	90
12	Inflammatory markers, lipoprotein components and risk of major cardiovascular events in 65,005 men and women in the Apolipoprotein MOrtality RISk study (AMORIS) 2010 ·Atherosclerosis ·Ingar Holme, Are H. Aastveit, Niklas Hammar, Ingmar Jungner, Göran Walldius	49
13	Dyslipidemia is a strong predictor of myocardial infarction in subjects with chronic kidney disease 2010 ·Annals of Medicine ·Martin J. Holzmann, Ingmar Jungner, Göran Walldius, Torbjörn Ivert, Tobias Nordqvist, Jan Östergren, Niklas Hammar	26
14	Lipoprotein Components and Risk of Congestive Heart Failure in 84 740 Men and Women in the Apolipoprotein MOrtality RISk Study (AMORIS) 2009 ·European Journal of Heart Failure ·Ingar Holme, Are H. Aastveit, Niklas Hammar, Ingmar Jungner, Göran Walldius	29
15	Levels of lipids and apolipoproteins in three cultures 2009 ·Atherosclerosis ·Amirreza Solhpour, (unknown), Nizal Sarrafzadegan, Sedigheh Asgary, Ken Williams, Ingmar Jungner, Are H. Aastveit, Göran Walldius, Allan D. Sniderman	16
16	Relationships between lipoprotein components and risk of myocardial infarction: age, gender and short versus longer follow‐up periods in the Apolipoprotein MOrtality RISk study (AMORIS) 2008 ·Journal of Internal Medicine ·Ingar Holme, Are H. Aastveit, Ingmar Jungner, Göran Walldius	87
17	The apoB/apoA‐I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid‐lowering therapy – a review of the evidence 2006 ·Journal of Internal Medicine ·Göran Walldius, Ingmar Jungner	441
18	Apolipoprotein B and apolipoprotein A‐I: risk indicators of coronary heart disease and targets for lipid‐modifying therapy 2004 ·Journal of Internal Medicine ·Göran Walldius, Ingmar Jungner	294
19	Prevalence of hereditary haemochromatosis in two Swedish urban areas 1989 ·Journal of Internal Medicine ·Leif Hallberg, Erik Björn‐Rasmussen, Ingmar Jungner	49
20	EFFECT OF ANABOLIC STEROIDS ON NITROGEN EXCRETION IN ACUTE POLIOMYELITIS 1959 ·The Lancet ·Ingmar Jungner, (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact